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Traditional chemotherapy is cytotoxic in nature and acts
primarily by eliminating neoplastic cells. Change in tumor
size, which is an indicator of change in the number of
neoplastic cells, evolved into the radiologic biomarker of
treatment response. The infectious, inflammatory, hemor-
rhagic and neoplastic complications of these therapies
have been well described. Significant advances in molecu-
lar cytogenetics has led to the development of molecular
targeted therapy which selectively acts on tumor cells and
modifies their biologic characteristics, by affecting various
cellular targets: growth factor receptors, signaling mole-
cules, cell-cycle proteins, molecules that direct apoptosis
and angiogenesis. This has required new means of asses-
sing tumor response to therapy. Additionally, a variety of
expected and unusual complications can develop in the
abdomen and pelvis in these patients. This presentation
highlights the imaging features of these complications
which may be confusing both radiologically and clinically.
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